Proficio Capital Partners LLC Takes $5.64 Million Position in DaVita Inc. (NYSE:DVA)

Proficio Capital Partners LLC purchased a new position in shares of DaVita Inc. (NYSE:DVA) during the 4th quarter, Holdings Channel.com reports. The firm purchased 37,687 shares of the company’s stock, valued at approximately $5,636,000.

A number of other hedge funds have also added to or reduced their stakes in DVA. Transcendent Capital Group LLC acquired a new stake in shares of DaVita in the 3rd quarter valued at $25,000. Quarry LP acquired a new position in shares of DaVita during the 3rd quarter worth $60,000. Venturi Wealth Management LLC lifted its position in shares of DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after buying an additional 152 shares during the last quarter. Versant Capital Management Inc boosted its stake in DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after buying an additional 169 shares in the last quarter. Finally, Blue Trust Inc. grew its position in DaVita by 39.7% in the fourth quarter. Blue Trust Inc. now owns 461 shares of the company’s stock valued at $76,000 after acquiring an additional 131 shares during the last quarter. 90.12% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on DVA shares. Sanford C. Bernstein set a $184.00 price target on shares of DaVita in a research note on Friday, February 21st. Barclays increased their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. Finally, Cowen reaffirmed a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $166.33.

DaVita Stock Performance

DaVita stock opened at $142.82 on Tuesday. The business has a 50 day moving average of $160.45 and a 200-day moving average of $158.18. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. DaVita Inc. has a 1 year low of $124.78 and a 1 year high of $179.60. The company has a market capitalization of $11.43 billion, a P/E ratio of 13.30, a P/E/G ratio of 1.07 and a beta of 0.94.

DaVita (NYSE:DVA) last released its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, equities research analysts predict that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.